Abstract
Objective
To evaluate the role and possible complications of tumor resection in the management of glioblastoma (GBM) in a series of patients 80 years of age and older with review of literature.
Methods
The authors retrospectively analyzed cases involving patients 80 years or older who underwent biopsy or initial resection of GBM at their hospital between 2007 and 2018. A total of 117 patients (mean age 82 years) met the inclusion criteria; 57 had resection (group A) and 60 had biopsy (group B). Functional outcomes and survival at follow-up were analyzed.
Results
Group A differed significantly from group B at baseline in having better WHO performance status, better ASA scores, more right-sided tumors, and no basal ganglia or “butterfly” gliomas. Nevertheless, 56% of group A patients had an ASA score of 3. Median survival was 9.5 months (95% CI 8–17 months) in group A, 4 months (95% CI 3.5–6 months) in group B, and 17.5 months (95% CI 12–24 months) in the 56% of group A patients treated with resection and Stupp protocol. Rates of postoperative neurologic and medical complications were almost identical in the 2 groups, but the rate of surgical site complications was substantially greater in group A (12% vs 5%). There was no significant difference in mean preoperative and postoperative KPS scores (group A).
Conclusions
In selected patients 80 years or older, radical removal of GBM was associated with acceptable survival and a low perioperative complication rate which is comparable to that of a biopsy. Although the median survival of the whole group was lower than reported for younger patients, a subgroup amenable to radical surgery and Stupp protocol achieved a median survival of 17.5 months.
Similar content being viewed by others
Abbreviations
- ASA:
-
American Society of Anesthesiologists
- EOR:
-
extent of resection
- GBM:
-
glioblastoma
- GTR:
-
gross-total resection
- KPS:
-
Karnofsky Performance Status
- STR:
-
subtotal resection
- WHO:
-
World Health Organization
- SEER:
-
Surveillance, Epidemiology and End Results
References
Almenawer SA, Badhiwala JH, Alhazzani W, Greenspoon J, Farrokhyar F, Yarascavitch B, Algird A, Kachur E, Cenic A, Sharieff W, Klurfan P, Gunnarsson T, Ajani O, Reddy K, Singh SK, Murty NK (2015) Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro-Oncology 17(6):868–881. https://doi.org/10.1093/neuonc/nou349
Batchelor TT, Dorfman MV, Hunter DJ (2005) Epidemiology of primary brain tumors. In: Black PM, Loeffler JS (eds) Cancer of the nervous system. Lippincott Williams & Wilkins, Philadelphia, pp 1–13
Benson AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K (1991) Oncologists’ reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. Journal of Clinical Oncology 9(11):2067–2075. https://doi.org/10.1200/JCO.1991.9.11.2067
Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival. J Neurosurg 117(6):1032–1038. https://doi.org/10.3171/2012.9.JNS12504
Brandes A, Fiorentino MV (1998) Treatment of High-Grade Gliomas in the Elderly. Oncology 55(1):1–6. https://doi.org/10.1159/000011827
Brandes AA, Monfardini S (2003) The treatment of elderly patients with high-grade gliomas. Semin Oncol 30(6 Suppl 19):58–62. https://doi.org/10.1053/j.seminoncol.2003.11.025
Cabantog AM, Bernstein M (1994) Complications of First Craniotomy for Intra-Axial Brain Tumour. Can J Neurol Sci 21(3):213–218. https://doi.org/10.1017/S0317167100041184
D’Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM (2015) The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma. World Neurosurg 84(4):913–919. https://doi.org/10.1016/j.wneu.2015.05.072
Dasenbrock HH, Liu KX, Devine CA, Chavakula V, Smith TR, Gormley WB, Dunn IF (2015) Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurg Focus 39(6):E12. https://doi.org/10.3171/2015.10.FOCUS15386
Ene CI, Cimino PJ, Fine HA, Holland EC (2020) Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients. Neurosurg Focus 49(4):E12. https://doi.org/10.3171/2020.7.FOCUS20418
Hanna C, Lawrie TA, Rogozińska E, Kernohan A, Jefferies S, Bulbeck H, Ali UM, Robinson T, Grant R (2020) Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database Syst Rev 3(3):CD013261. https://doi.org/10.1002/14651858.CD013261.pub2
Ius T, Somma T, Altieri R, Angileri FF, Barbagallo GM, Cappabianca P, Certo F, Cofano F, D’Elia A, Della Pepa GM, Esposito V, Fontanella MM, Germanò A, Garbossa D, Isola M, La Rocca G, Maiuri F, Olivi A, Panciani PP et al (2020) Is age an additional factor in the treatment of elderly patients with glioblastoma? A new stratification model: an Italian Multicenter Study. Neurosurg Focus 49(4):E13. https://doi.org/10.3171/2020.7.FOCUS20420
Karsy M, Yoon N, Boettcher L, Jensen R, Shah L, MacDonald J, Menacho ST (2018) Surgical treatment of glioblastoma in the elderly: the impact of complications. J Neuro-Oncol 138(1):123–132. https://doi.org/10.1007/s11060-018-2777-9
Laigle-Donadey F, Delattre J-Y (2006) Glioma in the elderly. Curr Opin Oncol 18(6). https://doi.org/10.1097/01.cco.0000245324.19411.19
Lowry JK, Snyder JJ, Lowry PW (1998) Brain Tumors in the Elderly. Arch Neurol 55(7). https://doi.org/10.1001/archneur.55.7.922
Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C (2005) Is older age associated with a worse prognosis due to different patterns of care? Cancer 103(6):1234–1244. https://doi.org/10.1002/cncr.20895
Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13(9):916–926. https://doi.org/10.1016/S1470-2045(12)70265-6
Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, Anile C (2006) Glioblastoma Multiforme in the Elderly: A Therapeutic Challenge. J Neuro-Oncol 76(2):159–163. https://doi.org/10.1007/s11060-005-4711-1
Menei P, Metellus P (2010) Traitement chirurgical des glioblastomes. Neurochirurgie 56(6). https://doi.org/10.1016/j.neuchi.2010.07.015
Minniti G, Lombardi G, Paolini S (2019) Glioblastoma in Elderly Patients: Current Management and Future Perspectives. Cancers 11(3):336. https://doi.org/10.3390/cancers11030336
Moroney C, Perry DSTJR, Bilodeau D, Mueller C, Soliman H, Myrehaug S, Sahgal A, Tseng C-L, Tsao MN (2017) Hospitalizations in elderly glioblastoma patients. Ann Palliat Med 6(S2):S161–S169. https://doi.org/10.21037/apm.2017.06.02
Noorbakhsh A, Tang JA, Marcus LP, McCutcheon B, Gonda DD, Schallhorn CS, Talamini MA, Chang DC, Carter BS, Chen CC (2014) Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis. J Neurosurg 120(1):31–39. https://doi.org/10.3171/2013.9.JNS13877
Oberheim Bush NA, Hervey-Jumper SL, Berger MS (2019) Management of Glioblastoma Present and Future. World Neurosurg 131:328–338. https://doi.org/10.1016/j.wneu.2019.07.044
Pérez-Larraya JG, Ducray F, Chinot O, Catry-Thomas I, Taillandier L, Guillamo J-S, Campello C, Monjour A, Cartalat-Carel S, Barrie M, Huchet A, Beauchesne P, Matta M, Mokhtari K, Tanguy M-L, Honnorat J, Delattre J-Y (2011) Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial. J Clin Oncol 29(22):3050–3055. https://doi.org/10.1200/JCO.2011.34.8086
Piccirilli M, Bistazzoni S, Gagliardi FM, Landi A, Santoro A, Giangaspero F, Salvati M (2006) Treatment of Glioblastoma Multiforme in Elderly Patients. Clinico-therapeutic Remarks in 22 Patients Older than 80 Years. Tumori 92(2):98–103. https://doi.org/10.1177/030089160609200203
Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y (2012) Primary brain tumours in adults. Lancet 379(9830):432–446. https://doi.org/10.1016/S0140-6736(11)61346-9
Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF (2013) Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. J Neurosurg 118(4):786–798. https://doi.org/10.3171/2012.10.JNS112268
Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J (2003) Debulking or biopsy of malignant glioma in elderly people – a randomised study. Acta Neurochir 145(1):5–10. https://doi.org/10.1007/s00701-002-1030-6
Yin A, Cai S, Dong Y, Zhang L, Liu B, Cheng J, Zhang X (2014) A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients. J Neuro-Oncol 116(2):315–324. https://doi.org/10.1007/s11060-013-1294-0
Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabbro M, Bessaoud F, Taillandier L, Ducray F, Bauchet F, Wager M, Faillot T, Capelle L, Loiseau H, Kerr C, Menei P, Duffau H, Figarella-Branger D, Chinot O et al (2014) Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France. Neurosurg Rev 37(3):415–424. https://doi.org/10.1007/s10143-014-0528-8
Acknowledgements
We are grateful to Anne Stanford, ELS, for English language editing. The authors thank the ARTC (Association Recherche contre les Tumeurs Cérébrales) for their help.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
For this type of study, formal consent is not required.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Brain Tumors
Rights and permissions
About this article
Cite this article
Niare, M., Desrousseaux, J., Cavandoli, C. et al. Outcome of glioblastoma resection in patients 80 years of age and older. Acta Neurochir 164, 373–383 (2022). https://doi.org/10.1007/s00701-021-04776-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-021-04776-5